XML 222 R88.htm IDEA: XBRL DOCUMENT v3.24.3
SCHEDULE OF RESTRICTED STOCK AWARDS ACTIVITY (Details) - $ / shares
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]              
Number of shares, nonvested beginning balance
Weighted average grant date fair value, nonvested beginning balance
Number of shares, nonvested granted  
Weighted average grant date fair value, nonvested granted  
Number of shares, nonvested vested (600,000)   (300,000)
Weighted average grant date fair value, nonvested vested $ 0.01   $ 0.01
Number of shares, nonvested forfeitures   4,705,000
Weighted average grant date fair value, nonvested forfeitures    
Number of shares, nonvested assumed due to titan merger vested and unreleased     1,405,000     1,405,000  
Weighted Average Grant Date Fair Value, Nonvested Beginning balance     $ 0.01     $ 0.01  
Number of shares, nonvested assumed due to titan merger unvested     3,600,000     3,600,000  
Weighted Average Grant Date Fair Value, Nonvested Beginning balance     $ 0.01     $ 0.01  
Weighted average remaining contractual term years, Acquired concurrent with the Titan Merger     2 years 7 months 13 days        
Number of shares, nonvested outstanding, ending balance     3,000,000      
Weighted average grant date fair value, nonvested outstanding, ending balance     $ 0.01      
Weighted average remaining contractual term years, outstanding nonvested     1 year 11 months 12 days        
Number of shares, nonvested vested and unreleased ending balance     2,005,000        
Weighted average grant date fair value, vested and unreleased     $ 0.01        
Number of shares, nonvested beginning balance 5,005,000
Weighted average grant date fair value, nonvested ending balance $ 0.01
Weighted average remaining contractual term years, nonvested     2 years 6 months 3 days        
Number of shares, nonvested vested 600,000   300,000
Number of shares, nonvested forfeitures   (4,705,000)
Number of shares, nonvested outstanding, ending balance     3,000,000      
Weighted average grant date fair value, nonvested outstanding, ending balance     $ 0.01